NovAccess Global Inc
NovAccess Global Inc., a biopharmaceutical company, engages in the development of novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc. was incorporated in 1997 and is headquartered in New York, New York.
NovAccess Global Inc (XSNX) - Total Liabilities
Latest total liabilities as of September 2024: $7.70 Million USD
Based on the latest financial reports, NovAccess Global Inc (XSNX) has total liabilities worth $7.70 Million USD as of September 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
NovAccess Global Inc - Total Liabilities Trend (2001–2024)
This chart illustrates how NovAccess Global Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
NovAccess Global Inc Competitors by Total Liabilities
The table below lists competitors of NovAccess Global Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
MPX International Corp
PINK:MPXOF
|
USA | $37.24 Million |
|
SIG plc
LSE:SHI
|
UK | GBX1.12 Billion |
|
Belmont Resources Inc
PINK:BELMF
|
USA | $136.24K |
Liability Composition Analysis (2001–2024)
This chart breaks down NovAccess Global Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.01 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.04 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 28.14 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how NovAccess Global Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for NovAccess Global Inc (2001–2024)
The table below shows the annual total liabilities of NovAccess Global Inc from 2001 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-09-30 | $7.86 Million | 0.00% |
| 2023-09-30 | $7.86 Million | +64.52% |
| 2022-09-30 | $4.78 Million | +15.52% |
| 2021-09-30 | $4.14 Million | +15.86% |
| 2020-09-30 | $3.57 Million | +45.64% |
| 2019-09-30 | $2.45 Million | -48.85% |
| 2018-09-30 | $4.79 Million | +338.61% |
| 2017-09-30 | $1.09 Million | +20.54% |
| 2016-09-30 | $906.35K | -6.96% |
| 2015-09-30 | $974.12K | +0.19% |
| 2014-09-30 | $972.24K | +2.98% |
| 2013-09-30 | $944.14K | +25.61% |
| 2012-09-30 | $751.65K | +2.99% |
| 2011-09-30 | $729.82K | -22.76% |
| 2010-09-30 | $944.83K | +5.82% |
| 2009-09-30 | $892.84K | +185.54% |
| 2008-09-30 | $312.69K | 0.00% |
| 2007-09-30 | $312.69K | -46.88% |
| 2006-09-30 | $588.70K | -39.57% |
| 2005-09-30 | $974.23K | +913.11% |
| 2004-09-30 | $96.16K | -76.78% |
| 2002-09-30 | $414.20K | +12.89% |
| 2001-09-30 | $366.91K | -- |